205 related articles for article (PubMed ID: 21467599)
1. Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.
Castro-Pastrana LI; Carleton BC
J Popul Ther Clin Pharmacol; 2011; 18():e76-88. PubMed ID: 21467599
[TBL] [Abstract][Full Text] [Related]
2. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Liu R; Zhang P
BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
[TBL] [Abstract][Full Text] [Related]
3. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
[TBL] [Abstract][Full Text] [Related]
4. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
7. Monitoring medicines use: the role of the clinical pharmacologist.
Williams D
Br J Clin Pharmacol; 2012 Oct; 74(4):685-90. PubMed ID: 22554404
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
Carleton B; Poole R; Smith M; Leeder J; Ghannadan R; Ross C; Phillips M; Hayden M
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):713-21. PubMed ID: 19507171
[TBL] [Abstract][Full Text] [Related]
9. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
10. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in pediatrics.
Bouquet É; Star K; Jonville-Béra AP; Durrieu G
Therapie; 2018 Apr; 73(2):171-180. PubMed ID: 29598957
[TBL] [Abstract][Full Text] [Related]
12. Veterinary pharmacovigilance in India: A need of hour.
Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
[TBL] [Abstract][Full Text] [Related]
13. Pharmacovigilance: Importance, concepts, and processes.
Kumar A
Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
[No Abstract] [Full Text] [Related]
14. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.
Neubert A; Dormann H; Prokosch HU; Bürkle T; Rascher W; Sojer R; Brune K; Criegee-Rieck M
Br J Clin Pharmacol; 2013 Sep; 76 Suppl 1(Suppl 1):69-77. PubMed ID: 23586589
[TBL] [Abstract][Full Text] [Related]
15. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
[TBL] [Abstract][Full Text] [Related]
16. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
17. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
Katusiime B; Semakula D; Lubinga SJ
Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
